The term theranostics is the combination of a diagnostic tool that helps to define the right
therapeutic tool for specific disease. It signifies the “we know which sites require treatment …

Thyroid cancer is the most common endocrine malignancy with almost one million people
living with thyroid cancer in the United States. Although early-stage well-differentiated …

Abstract The guidelines Thyroid Cancer 2022 are prepared based on previous Polish
recommendations updated in 2018. They consider international guidelines—American …

Anaplastic thyroid carcinoma (ATC) responds for the majority of death of thyroid carcinoma
and often causes chemotherapy resistance. We investigated the influence of circEIF6 …

Significant advances have been made in thyroid cancer research in recent years, therefore
relevant clinical guidelines need to be updated. The current Polish guidelines “Diagnostics …

Background The prognosis for patients with advanced differentiated thyroid carcinoma
(ADTC) with disseminated distant metastases is very poor. Tyrosine kinase inhibitors …

Background Lenvatinib treatment of 24 mg/day for radioiodine-refractory differentiated
thyroid carcinoma (RRDTC) patients was almost intolerable, with high rates of dose …

We report a case of an elderly woman presenting with a huge cervical mass invading the
tracheal lumen. Diagnosed as invasive poorly differentiated thyroid cancer, after an …

Patients with radioiodine-refractory (RAIR) differentiated thyroid carcinoma (DTC) represent
a challenging subgroup of DTC because they are at higher risk of cancer-related death …

Differentiated thyroid cancer (DTC) arises from follicular cells and includes papillary and
follicular cancers that represent the majority (> 90%) of all thyroid cancers [1]. It represents a …